Browsing Tag
ASX:4DX
3 posts
4DMedical’s CT:VQ clearance could mark the end of nuclear VQ scans—is the industry ready for software-first lung imaging?
4DMedical’s FDA-cleared CT:VQ may replace nuclear lung scans with software-powered diagnostics. Explore how this breakthrough is reshaping imaging standards.
How 4DMedical’s CT:VQ is rewriting the rules of lung imaging—no radiotracers, no waiting rooms, just pixels
CT:VQ gets FDA clearance—and 4DMedical may be the new standard in lung imaging. Discover how this Aussie SaaS medtech is reshaping respiratory diagnostics.
Why 4DMedical stock is suddenly soaring—and how FDA approval could open a billion-dollar market
4DMedical stock jumps 35% as CT:VQ earns FDA clearance. Find out how this breakthrough in lung imaging is reshaping the USD $1.1B VQ scan market.